REFERENCES
- Neu HC, Saha G, Chin NX. Comparative “in vitro” activity and 0-lactamase stability of FK 482, a new oral cephalosporin. Antimicrob Agents Chemother 1989; 33: 1795–1800.
- Wise R, Andrews JM, Thomberg D. The in vitro activity of cefdinir (FK 482), a new oral cephalosporin. J Antimicrob Chemother 1991; 28: 239–248.
- Lennette EH, Balows A, Hauser W, Shadomy HJ. Manual of Clinical Microbiology. 4th ed. Washington D. C.: American Socety of Microbiology, 1985.
- O'Callaghan CH, Morris A, Kirby SM, Shingler AH. Novel method for detection of P-lactamase by using a chro-mogenic cephalosporin substrate. Antimicrob Agents Chemother 1972; 1: 283–288.
- Mattaw M, Harris AM, Marshall MJ, Ross GW. The use of analytical isoelectric focusing for detection and identifica-tion of 0-lactamases. J Gen Microbiol 1975; 88: 169–178.
- National Committee for Clinical Laboratory Standards Approved standard M 7-A2. Methods for dilution antimicro-bial susceptibility tests for bacteria that grow aerobically. National Committee for Clinical Laboratory Standards, Villanova, PA, 1990.
- National Committee for Clinical Laboratory Standards Approved standard M 100-54 (M7-A2). Performance stan-dards for antimicrobial susceptibility testing: fourth informational supplement. National Committee for Clinical Laboratory Standards, Villanova, PA, 1992.
- Doern GV, Sieberg KG, Hallick LM, Morse SA. Antibiotic susceptibility of lactamase producing strains of Branhamella catarrhalis. Antimicrob Agents Chemother 1980; 17: 24–29.
- Perea EJ, Garcia Iglesias MC. Comparative in-vitro activity of cefdinir against multiresistant Haemophilus influen-zae. J Antimicrob Chemother 1994; 34: 161–164.
- Tomatsu K, Masuyoshi S, Hirano M, et al. In vitro and in vivo evaluations of a new broad-spectrum oral cephalosporin, BMY-28232 and its prodrug esters. Antimicrob Agents Chemother 1989; 33: 489–497.
- Blandino G, Caccamo F, Di Marco R, Nicoletti A, Speciale A. Bactericidal activity and postantibiotic effect of cefdinir (CI 983, FK 482) against selected pathogens. Drugs Exptl Clin Res 1992; XVIII: 319-327.